Core enzymes such as METTL3, ALKBH5 and IGF2BP proteins play essential roles not only in cancer but also in normal tissue homeostasis, raising concerns about toxicity and selectivity when targeting these proteins therapeutically [10,167]. This evidence concerns the gene ALKBH5 and cancer.